Related Experiment Video
Updated: Apr 16, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Sudden cardiac death: a modern pathology approach to hypertrophic cardiomyopathy
Linda Kocovski1, John Fernandes
1From the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Kocovski); and the Regional Forensic Pathology Unit, Hamilton General Hospital, Hamilton, Ontario, Canada (Dr Fernandes).
Insights
Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in young people, often presenting without warning. Genetic testing is crucial for family members to assess and mitigate risks associated with HCM.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death in adolescents and young adults.
- Sudden cardiac death during exertion, such as sports, can be the initial presentation of HCM.
- Clinical symptoms include exertional dyspnea, angina, and syncope.
Purpose of the Study:
- To highlight the pathological findings of hypertrophic cardiomyopathy.
- To emphasize the importance of molecular analysis for genetic counseling.
- To inform about risk assessment and reduction strategies for sudden cardiac death in families.
Main Methods:
- Postmortem examination revealing asymmetrical septal thickening and left ventricular outflow tract mural plaque.
- Histologic analysis demonstrating cardiac myocyte hypertrophy, myofiber disarray, and fibrosis.
- Molecular analysis to identify known genetic abnormalities.
Main Results:
- Pathological hallmarks include specific cardiac structural changes and fibrosis.
- Genetic abnormalities are identifiable through molecular analysis.
- Identification of genetic causes facilitates risk stratification.
Conclusions:
- Hypertrophic cardiomyopathy presents significant risks, including sudden cardiac death, particularly in young individuals.
- Understanding the genetic basis of HCM is vital for effective genetic counseling.
- Early identification and risk assessment through molecular analysis can help reduce sudden cardiac death in affected families.
Abstract:
Hypertrophic cardiomyopathy is one of the most common causes of sudden cardiac death among young adults and adolescents. Unfortunately, the first manifestation of the condition may be sudden death during exertion, such as sporting activities. Other clinical symptoms include exertional dyspnea, angina, and syncope. Postmortem examination often reveals asymmetrical septal thickening and mural plaque formation in the left ventricular outflow tract. Histologic analysis shows cardiac myocyte hypertrophy, myofiber disarray, and interstitial and replacement fibrosis. Molecular analysis for known genetic abnormalities is essential to genetic counseling of living relatives of decedents to assess and reduce the risk of sudden cardiac death from hypertrophic cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction

